19
Participants
Start Date
December 31, 2009
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
MVA.HIVconsv low dose
Three intramuscular injections of MVA.HIVconsv alone at a dose of 1x10\^8 pfu at week 0, 4 and 12.
Placebo low dose
Three intramuscular injections of placebo alone (200ul) at week 0, 4 and 12.
MVA.HIVconsv high dose
Three intramuscular injections of MVA.HIVconsv alone at a dose of 4x10\^8 pfu at week 0, 4 and 12.
Placebo high dose
Three intramuscular injections of placebo alone (800ul) at week 0, 4 and 12.
Weatherall Institute of Molecular Medicine, Oxford
Oxford Genitourinary Medicine, Oxford
Collaborators (1)
Medical Research Council
OTHER_GOV
University of Oxford
OTHER